TY  - GEN
AU  - Witteles, Ronald M
AU  - Garcia-Pavia, Pablo
AU  - Damy, Thibaud
AU  - Grogan, Martha
AU  - Sheikh, Farooq H
AU  - Morbach, Caroline
AU  - Bender, Shaun
AU  - Exter, Jason
AU  - Eraly, Satish A
AU  - Fontana, Marianna
PY  - 2025
UR  - https://hdl.handle.net/20.500.12105/26845
AB  - Patients with transthyretin amyloidosis with cardiomyopathy (ATTR-CM) have high mortality and morbidity. Vutrisiran, a subcutaneous RNA interference therapeutic, reduced the composite of all-cause mortality (ACM) and cardiovascular (CV) events (CV...
LA  - eng
PB  - Elsevier
KW  - HELIOS-B
KW  - cardiovascular events
KW  - cardiovascular mortality
KW  - transthyretin amyloidosis with cardiomyopathy
KW  - vutrisiran
TI  - Vutrisiran Improves Survival and Reduces Cardiovascular Events in ATTR Amyloid Cardiomyopathy: HELIOS-B.
TY  - research article
ER  -